REPLIGEN CORP Prepaid Taxes
REPLIGEN CORP (RGEN) had Prepaid Taxes of $12.35 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidTaxes · last filed 2026-02-26
- 2025-12-31: Prepaid Taxes $12.35M.
- 2024-12-31: Prepaid Taxes $10.03M.
- 2023-12-31: Prepaid Taxes $10.53M; Prepaid Taxes as first filed $10.23M.
- 2022-12-31: Prepaid Taxes $519.00K.
| Period end | Prepaid Taxes | Prepaid Taxes as first filed |
|---|---|---|
| 2025-12-31 | $12.35M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $10.03M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $10.53M 10-K · filed 2025-03-14 | $10.23M 10-K · filed 2024-02-22 |
| 2022-12-31 | $519.00K 10-K/A · filed 2024-11-18 | |
| 2021-12-31 | $3.97M 10-K · filed 2023-02-22 | |
| 2020-12-31 | $2.65M 10-K · filed 2022-02-17 | |
| 2019-12-31 | $2.72M 10-K · filed 2021-02-24 | |
| 2018-12-31 | $843.00K 10-K · filed 2020-02-26 | |
| 2017-12-31 | $311.00K 10-K · filed 2019-03-01 | |
| 2016-12-31 | $626.00K 10-K · filed 2018-02-22 | $73.00K 10-K · filed 2017-02-23 |
| 2015-12-31 | $105.00K 10-K · filed 2017-02-23 | |
| 2014-12-31 | $220.00K 10-K · filed 2016-02-25 | $220.03K 10-K · filed 2015-03-17 |
| 2013-12-31 | $135.10K 10-K · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |